The purpose of this guideline is to standardize the registration and approval of registered applicants and examiners for medical device products for the treatment of rare diseases, to benefit the patients, to scientifically solve the difficult points of clinical evaluation for the treatment of rare diseases, to rationally relieve the clinic, to promote the products to clinical use as soon as possible by means of conditional approval.